MIR100HG and acute promyelocytic leukemia: Therefore, inhibition of MIR100HG is a novel approach to control APL cell proliferation, which can be considered for the treatment of APL alone or in combination with existing treatments, or for patients who are resistant to conventional APL therapy (60).